S. Korea announces innovative syringe method to increase vaccine doses | Inquirer News

S. Korea announces innovative syringe method to increase vaccine doses

/ 11:47 AM February 28, 2021

Alt Syringe covid-19 vaccine

A medical worker prepares Pfizer’s COVID-19 vaccine at a hospital in central Seoul on Saturday. Yonhap via The Korea Herald/Asia News Network

SEOUL — South Korea’s health authorities on Saturday issued a new guideline to vaccination centers across the nation, asking medical staff members to maximize the number of jabs per vaccine bottle by utilizing state-of-the-art syringes.

One day after the start of the nation’s public vaccination program, the Korea Disease Control and Prevention Agency (KDCA) said a special model of locally produced syringes has paved the way for increasing the number of vaccine recipients by one to two per vaccine bottle.

Article continues after this advertisement

The breakthrough was made possible by the so-called low dead space (LDS) syringes designed to minimize wasted vaccine doses by reducing space between the needle and the plunger.

FEATURED STORIES

It was previously estimated that a bottle of AstraZeneca’s vaccine was enough to provide jabs to 10 people, while that of Pfizer came to six.

When using the LDS syringes, however, the KDCA believes a bottle of AstraZeneca’s vaccine can provide jabs for up to 12 people, while that of Pfizer’s can increase up to seven.

Article continues after this advertisement

“The previous estimate was based on ordinary types of syringes.

Article continues after this advertisement

Thus, the number of recipients can increase when we apply the LDS model,” an official from the Central Disease Control Headquarters said

Article continues after this advertisement

Authorities, however, said the actual number of additional recipients can still vary depending on the skills of each medical staff member.

“Although the new progress can only add a few thousands jabs for now, the figure is expected to expand significantly down the road when more Pfizer vaccines are supplied here,” said Chun Eun-mi, a professor at the Ewha Womans University Medical Center.

Article continues after this advertisement

South Korea has secured enough vaccines to inoculate 79 million people, which is much higher than the nation’s population of 52 million.

Of the volume, jabs produced by AstraZeneca account for 10 million, while those from Pfizer came to 13 million.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

The country aims to achieve herd immunity by November. Yonhap

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, South korea, syringe

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.